Dementia, Non-Alzheimer's


An overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Vascular dementia, which occurs after a stroke, is the second most common dementia type (after Alzheimer’s).

The Association for Frontotemporal Dementias

In addition to a thorough introduction to frontotemporal dementias, The Association for Frontotemporal Dementias provides specific diagnostic and clinical information for a variety of disorders, including Pick's Disease and progressive aphasia.

The Lewy Body Dementia Association

In addition to publishing a newsletter and hosting email support groups for care-givers and spouses of Lewy Body Dementia patients, the LBDA Web site contains patient care tips and links to scientific journal articles about LBD.

NINDS Dementia with Lewy Bodies Information Page

This page provides a succinct description of Lewy Body Dementia, as well as information about clinical trials.

NINDS Pick's Disease Information Page

The National Institute of Neurological Disorders and strokes briefly describes Pick's Disease and provides links to relevant clinical trials.

UCSF Memory and Aging Center

This University of California, San Francisco site offers information on different forms of dementia, along with healthy aging and memory.


Dana Articles

The Malignant Protein Puzzle

By: Lary C. Walker, Ph.D., and Mathias Jucker, Ph.D.

(Read Q&A with Lary C. Walker Ph.D.)
Studying how proteins such as PrP, amyloid beta, tau, and others aggregate and spread, and kill brain cells, represents a crucial new frontier in neuroscience for Alzheimer's, Parkinson's, CTE, and ALS.


Air Pollution Also Not Good For Your Brain

Recent research provides strong evidence that pollutants cause harms, and suggests underlying pathways and mechanisms. 


What Does it Mean to be ‘Amyloid Positive?’

Studies suggest amyloid accumulates for 3 decades or more before dementia symptoms show.


Target: Tau

Scientists have new insights into how the tau protein spreads within and harms the brain, in Alzheimer’s and other diseases--and tau-targeting therapies are now entering clinical trials.